📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: PanGenetics

1.1 - Company Overview

PanGenetics Logo

PanGenetics

Headquarter: The Netherlands
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of clinical development services for monoclonal antibodies targeting immune-mediated diseases, specializing in advancing candidates from late research stage through clinical proof of concept; based in Utrecht, the Netherlands, with an office in Cambridge, UK.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to PanGenetics

Neutrolis Logo

Neutrolis

HQ: United States Website
  • Description: Provider of candidate-stage, first-in-class anti-NET therapies, including the exDNASETM platform to create molecules that disassemble Neutrophil Extracellular Traps; NTR-L303 to resolve hyperinflammation and disrupt NET-immune complexes; NEU-101 for surface inflammation; and NET biomarkers to identify, treat, and monitor responsive patients.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Neutrolis company profile →
Shire Logo

Shire

HQ: Ireland Website
  • Description: Provider of biotechnology products focused on serving people with rare diseases, supported by a global sales and marketing infrastructure. Offers a broad portfolio with direct marketing capability in the US, Canada, UK, Republic of Ireland, France, Germany, Italy, and Spain.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Shire company profile →
Santarus Logo

Santarus

HQ: United States Website
  • Description: Provider of specialty biopharmaceutical products focused on acquiring, developing and commercializing proprietary therapies that address the needs of patients treated by physician specialists; current commercial efforts encompass five products, including UCERIS (budesonide) extended release tablets.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Santarus company profile →
Biosplice Logo

Biosplice

HQ: United States Website
  • Description: Provider of therapeutic solutions and clinical trials for tissue-level regeneration, developing therapies that modulate alternative splicing via CLK/DYRK kinase inhibition to treat diseases like osteoarthritis and cancer. Offerings include Lorecivivint, an injectable small molecule for knee osteoarthritis to reduce pain, improve function, and protect cartilage, with trials evaluating safety, efficacy, and dosing.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Biosplice company profile →
Recordati Logo

Recordati

HQ: Italy Website
  • Description: Provider of medications and treatment options across specialty and primary care, consumer healthcare, and rare diseases, focusing on the development and distribution of therapies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Recordati company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for PanGenetics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to PanGenetics

2.2 - Growth funds investing in similar companies to PanGenetics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for PanGenetics

4.2 - Public trading comparable groups for PanGenetics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to PanGenetics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About PanGenetics

What does PanGenetics do?

PanGenetics is a provider of clinical development services for monoclonal antibodies targeting immune-mediated diseases, specializing in advancing candidates from late research stage through clinical proof of concept; based in Utrecht, the Netherlands, with an office in Cambridge, UK.

Who are PanGenetics's competitors?

PanGenetics's competitors and similar companies include Neutrolis, Shire, Santarus, Biosplice, and Recordati.

Where is PanGenetics headquartered?

PanGenetics is headquartered in The Netherlands.

How many employees does PanGenetics have?

PanGenetics has 1,000 employees 🔒.

When was PanGenetics founded?

PanGenetics was founded in 2010 🔒.

What sector and industry vertical is PanGenetics in?

PanGenetics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for PanGenetics

Who are the top strategic acquirers in PanGenetics's sector and industry

Top strategic M&A buyers and acquirers in PanGenetics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for PanGenetics?

Top strategic M&A buyers groups and sectors for PanGenetics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in PanGenetics's sector and industry vertical

Which are the top PE firms investing in PanGenetics's sector and industry vertical?

Top PE firms investing in PanGenetics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in PanGenetics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in PanGenetics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in PanGenetics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to PanGenetics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in PanGenetics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for PanGenetics?

The key public trading comparables and valuation benchmarks for PanGenetics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for PanGenetics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for PanGenetics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in PanGenetics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for PanGenetics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in PanGenetics's' sector and industry vertical?

Access recent funding rounds and capital raises in PanGenetics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for PanGenetics